Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Depletion of Alveolar Macrophages Does Not Prevent Hantavirus Disease Pathogenesis in Golden Syrian Hamsters.

Hammerbeck CD, Brocato RL, Bell TM, Schellhase CW, Mraz SR, Queen LA, Hooper JW.

J Virol. 2016 Jun 24;90(14):6200-6215. doi: 10.1128/JVI.00304-16. Print 2016 Jul 15.

2.

The Science of Firescapes: Achieving Fire-Resilient Communities.

Smith AMS, Kolden CA, Paveglio TB, Cochrane MA, Bowman DM, Moritz MA, Kliskey AD, Alessa L, Hudak AT, Hoffman CM, Lutz JA, Queen LP, Goetz SJ, Higuera PE, Boschetti L, Flannigan M, Yedinak KM, Watts AC, Strand EK, van Wagtendonk JW, Anderson JW, Stocks BJ, Abatzoglou JT.

Bioscience. 2016 Feb 1;66(2):130-146. doi: 10.1093/biosci/biv182. Epub 2016 Feb 3.

3.

A lethal disease model for hantavirus pulmonary syndrome in immunosuppressed Syrian hamsters infected with Sin Nombre virus.

Brocato RL, Hammerbeck CD, Bell TM, Wells JB, Queen LA, Hooper JW.

J Virol. 2014 Jan;88(2):811-9. doi: 10.1128/JVI.02906-13. Epub 2013 Nov 6.

4.

Aspirin acetylates nitric oxide synthase type 3 in platelets thereby increasing its activity.

O'Kane P, Xie L, Liu Z, Queen L, Jackson G, Ji Y, Ferro A.

Cardiovasc Res. 2009 Jul 1;83(1):123-30. doi: 10.1093/cvr/cvp120. Epub 2009 Apr 17.

PMID:
19377066
5.

Age decreases nitric oxide synthesis and responsiveness in human platelets and increases formation of monocyte-platelet aggregates.

Goubareva I, Gkaliagkousi E, Shah A, Queen L, Ritter J, Ferro A.

Cardiovasc Res. 2007 Sep 1;75(4):793-802. Epub 2007 May 24.

PMID:
17572401
6.

beta-Actin regulates platelet nitric oxide synthase 3 activity through interaction with heat shock protein 90.

Ji Y, Ferracci G, Warley A, Ward M, Leung KY, Samsuddin S, Lévêque C, Queen L, Reebye V, Pal P, Gkaliagkousi E, Seager M, Ferro A.

Proc Natl Acad Sci U S A. 2007 May 22;104(21):8839-44. Epub 2007 May 14.

7.

Increased platelet aggregation in vivo in the Zucker Diabetic Fatty rat: differences from the streptozotocin diabetic rat.

Paul W, Queen LR, Page CP, Ferro A.

Br J Pharmacol. 2007 Jan;150(1):105-11. Epub 2006 Nov 13.

8.

Mechanisms underlying beta2-adrenoceptor-mediated nitric oxide generation by human umbilical vein endothelial cells.

Queen LR, Ji Y, Xu B, Young L, Yao K, Wyatt AW, Rowlands DJ, Siow RC, Mann GE, Ferro A.

J Physiol. 2006 Oct 15;576(Pt 2):585-94. Epub 2006 Jul 27.

9.

Beta-adrenergic receptors and nitric oxide generation in the cardiovascular system.

Queen LR, Ferro A.

Cell Mol Life Sci. 2006 May;63(9):1070-83. Review.

PMID:
16568246
10.

SIV-specific T lymphocyte responses in PBMC and lymphoid tissues of SIV-infected pigtailed macaques during suppressive combination antiretroviral therapy.

Carruth LM, Zink MC, Tarwater PM, Miller MD, Li M, Queen LA, Mankowski JL, Shen A, Siliciano RF, Clements JE.

J Med Primatol. 2005 Jun;34(3):109-21.

PMID:
15860119
11.

Nitric oxide-dependent beta2-adrenergic dilatation of rat aorta is mediated through activation of both protein kinase A and Akt.

Ferro A, Coash M, Yamamoto T, Rob J, Ji Y, Queen L.

Br J Pharmacol. 2004 Oct;143(3):397-403. Epub 2004 Sep 6.

12.

Nitric oxide generation mediated by beta-adrenoceptors is impaired in platelets from patients with Type 2 diabetes mellitus.

Queen LR, Ji Y, Goubareva I, Ferro A.

Diabetologia. 2003 Nov;46(11):1474-82. Epub 2003 Oct 23.

PMID:
14574451
13.

Aspirin modifies nitric oxide synthase activity in platelets: effects of acute versus chronic aspirin treatment.

O'Kane PD, Queen LR, Ji Y, Reebye V, Stratton P, Jackson G, Ferro A.

Cardiovasc Res. 2003 Jul 1;59(1):152-9.

PMID:
12829186
14.
15.

beta(2)-adrenoceptors activate nitric oxide synthase in human platelets.

Queen LR, Xu B, Horinouchi K, Fisher I, Ferro A.

Circ Res. 2000 Jul 7;87(1):39-44.

PMID:
10884370
16.

Activation of nitric oxide synthase by beta 2-adrenoceptors in human umbilical vein endothelium in vitro.

Ferro A, Queen LR, Priest RM, Xu B, Ritter JM, Poston L, Ward JP.

Br J Pharmacol. 1999 Apr;126(8):1872-80.

17.

Organ-specific, phylogenetic, and ontogenetic distribution of the epidermolysis bullosa acquisita antigen.

Paller AS, Queen LL, Woodley DT, Lane AT, Gammon WR, Briggaman RA.

J Invest Dermatol. 1986 Apr;86(4):376-9.

18.

A mouse monoclonal antibody against a newly discovered basement membrane component, the epidermolysis bullosa acquisita antigen.

Paller AS, Queen LL, Woodley DT, Gammon WR, O'Keefe EJ, Briggaman RA.

J Invest Dermatol. 1985 Mar;84(3):215-7.

19.

Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita.

Woodley DT, Briggaman RA, O'Keefe EJ, Inman AO, Queen LL, Gammon WR.

N Engl J Med. 1984 Apr 19;310(16):1007-13.

PMID:
6369131
20.
21.

Detection of melanomas. Approach with radiolabeled false precursors of melanin synthesis.

Levine N, Queen L, Chalom A.

Arch Dermatol. 1983 Apr;119(4):295-9.

PMID:
6838235
22.

Animal model of intracutaneous melanoma.

Levine N, Queen L, Chalom AA, Daniels LJ.

J Invest Dermatol. 1982 Mar;78(3):191-3.

23.

A comparison of externality, anxiety, and life satisfaction in two aged populations.

Queen L, Freitag CB.

J Psychol. 1978 Jan;98(1st Half):71-4.

PMID:
625028

Supplemental Content

Support Center